Interaction of rocuronium with human liver cytochromes P450
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33154985" target="_blank" >RIV/61989592:15110/15:33154985 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00098892:_____/15:#0000937
Výsledek na webu
<a href="http://www.sciencedirect.com/science/article/pii/S1347861314000279" target="_blank" >http://www.sciencedirect.com/science/article/pii/S1347861314000279</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jphs.2014.12.006" target="_blank" >10.1016/j.jphs.2014.12.006</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Interaction of rocuronium with human liver cytochromes P450
Popis výsledku v původním jazyce
Rocuronium is a neuromuscular blocking agent acting as a competitive antagonist of acetylcholine. Results of an inhibition of eight individual liver microsomal cytochromes P450 (CYP) are presented. As the patients are routinely premedicated with diazepam, possible interaction of diazepam with rocuronium has been also studied. Results indicated that rocuronium interacts with human liver microsomal CYPs by binding to the substrate site. Next, concentration dependent inhibition of liver microsomal CYP3A4 down to 42% (at rocuronium concentration 189 ?M) was found. This effect has been confirmed with two CYP3A4 substrates, testosterone (formation of 6?-hydroxytestosterone) and diazepam (temazepam formation). CYP2C9 and CYP2C19 activities were inhibited downto 75-80% (at the same rocuronium concentration). Activities of other microsomal CYPs have not been inhibited by rocuronium. To prove the possibility of rocuronium interaction with other drugs (diazepam), the effect of rocuronium on form
Název v anglickém jazyce
Interaction of rocuronium with human liver cytochromes P450
Popis výsledku anglicky
Rocuronium is a neuromuscular blocking agent acting as a competitive antagonist of acetylcholine. Results of an inhibition of eight individual liver microsomal cytochromes P450 (CYP) are presented. As the patients are routinely premedicated with diazepam, possible interaction of diazepam with rocuronium has been also studied. Results indicated that rocuronium interacts with human liver microsomal CYPs by binding to the substrate site. Next, concentration dependent inhibition of liver microsomal CYP3A4 down to 42% (at rocuronium concentration 189 ?M) was found. This effect has been confirmed with two CYP3A4 substrates, testosterone (formation of 6?-hydroxytestosterone) and diazepam (temazepam formation). CYP2C9 and CYP2C19 activities were inhibited downto 75-80% (at the same rocuronium concentration). Activities of other microsomal CYPs have not been inhibited by rocuronium. To prove the possibility of rocuronium interaction with other drugs (diazepam), the effect of rocuronium on form
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FR - Farmakologie a lékárnická chemie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT13591" target="_blank" >NT13591: Primární kultury lidských hepatocytů jako model pro toxikologické, farmakologické a biochemické studie v transplantační medicíně</a><br>
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Pharmacological Sciences
ISSN
1347-8613
e-ISSN
—
Svazek periodika
127
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
JP - Japonsko
Počet stran výsledku
6
Strana od-do
190-195
Kód UT WoS článku
—
EID výsledku v databázi Scopus
—